News FDA approves Pfizer's epoetin biosimilar Retacrit Epoetin alfa biosimilars available in EU for more than a decade
News Pfizer eyes AI-powered drug discovery and development softwa... Pfizer has partnered with a ‘computation-driven’ pharmaceutical technology company to develop a drug discovery platform powered by artificial intelligence (AI).
News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety Conference London 2018
News Pfizer's lung cancer drug dacomitinib gets fast US review Drug beat AZ's Iressa in head-to-head trial, concerns over side-effects
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.